SCHEMBL3661402

SCHEMBL3661402

O=C(O)CN(C(=O)c1ccccc1)c1ccc(O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
ADRA2C P18825 1/20 0.53
CES2 O00748 1/20 0.46
TSHR P16473 1/20 0.44
RORC P51449 1/20 0.44
ESR1 P03372 2/20 0.43
ESR2 Q92731 2/20 0.43
CHRM2 P08172 1/20 0.43
CHRM3 P20309 1/20 0.43
POLB P06746 1/20 0.42
PDK1 Q15118 1/20 0.42
PDK2 Q15119 1/20 0.42
PDK4 Q16654 1/20 0.42
MEN1 O00255 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42
PTGIR P43119 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9716677 0.93 ADRA2C (0.53) ALDH1A1ADRA2CCES2TSHRESR1
SCHEMBL3656192 0.93 ALDH1A1 (0.51) ALDH1A1ADRA2CCES2TSHRESR1
SCHEMBL698882 0.89 ADRA2C (0.64) ALDH1A1ADRA2CTSHRRORCPOLB
SCHEMBL7623744 0.87 ALDH1A1 (0.57) ALDH1A1ADRA2CCES2TSHRRORC
SCHEMBL11734968 0.86 ALDH1A1 (0.48) ALDH1A1ADRA2CTSHRESR1ESR2
SCHEMBL10349935 0.85 MEN1 (0.56) ALDH1A1ADRA2CTSHRRORCPOLB
SCHEMBL11503382 0.82 ADRA2C (0.49) ALDH1A1ADRA2CTSHRPOLBPDK1
SCHEMBL11503381 0.82 ADRA2C (0.49) ALDH1A1ADRA2CTSHRPOLBPDK1
SCHEMBL4190476 0.82 ALDH1A1 (0.52) ALDH1A1ADRA2CCES2TSHRRORC
SCHEMBL3659973 0.82 TSHR (0.54) ALDH1A1TSHRESR2POLBPDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed
US-4002666-A SALT FORMATION WITH PHENYLETHYLAMINE, DECOMPOSITION, HYDROLYSIS NIPPON KAYAKU KABUSHIKI KAISHA (JA) 1977-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC ALDH1A1 2963/4885ADRA2C 4768/4885CES2 4498/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR ALDH1A1 1854/4885ADRA2C 2994/4885CES2 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.